Surrozen, Inc. (SRZN) vs Zentalis Pharmaceuticals, Inc. (ZNTL)
A side-by-side comparison of Surrozen, Inc. and Zentalis Pharmaceuticals, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
SRZN
Surrozen, Inc.
$26.37HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
ZNTL
Zentalis Pharmaceuticals, Inc.
$2.67HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — SRZN vs ZNTL
growth of $100 · dividends reinvested · last 6ySRZN -80.8% (-24.0%/yr)ZNTL -94.3% (-37.9%/yr)SRZN compounded faster over this window
SRZN ZNTL
SRZN vs ZNTL: by the numbers
- •SRZN is the larger company ($197M vs $190M market cap).
- •Both run net losses; ZNTL's is the smaller (0.00% vs -2885.33% net margin).
Metrics side by side
Valuation
| Metric | SRZN | ZNTL |
|---|---|---|
| P/S ratio | 17.13 | N/A |
| P/B ratio | N/A | 1.32 |
Profitability
| Metric | SRZN | ZNTL |
|---|---|---|
| Gross margin | 84.56% | 0.00% |
| Operating margin | -1210.58% | 0.00% |
| Net margin | -2885.33% | 0.00% |
| ROE | N/A | -121.76% |
| ROIC | -41.61% | -105.17% |
Growth (annualized)
| Metric | SRZN | ZNTL |
|---|---|---|
| Total return CAGR (5Y) | -20.80% | -47.34% |
Frequently asked
- How have SRZN and ZNTL total returns compared?
- Over the past 5 years, SRZN delivered -20.80% and ZNTL delivered -47.34% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.